OGA and lung adenocarcinoma: When cultured CL1-5 or A549 human lung adenocarcinoma cells were treated with an OGA inhibitor, either Thiamet G (TMG) or PUGNAc, to elevate O-GlcNAcylation, the amount of OGT protein decreased while that of OGA increased (Figure 1A).